You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

ACOG MEMBER SUBSCRIPTION ACCESS

If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these step-by-step instructions to access journal content with your member subscription.

PERIPARTUM HEART FAILURE IN A PATIENT TREATED PREVIOUSLY WITH DOXORUBICIN.

Davis, Lowell E. MD; Brown, Charles E. L. MD
Obstetrics & Gynecology:
Original Article: PDF Only
Abstract

Postpartum congestive heart failure developed in a primigravida seven years after doxorubicin therapy for osteosarcoma. Delayed cardiac toxicity may be affected by preeclampsia, anemia, or postoperative fluid management.

(C) 1988 The American College of Obstetricians and Gynecologists